Product: USP31 Antibody
Catalog: DF9989
Description: Rabbit polyclonal antibody to USP31
Application: WB IHC
Cited expt.: WB
Reactivity: Human, Mouse, Rat
Prediction: Pig, Bovine, Horse, Sheep, Dog
Mol.Wt.: 147 kDa; 147kD(Calculated).
Uniprot: Q70CQ4
RRID: AB_2843181

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Pig(92%), Bovine(92%), Horse(92%), Sheep(92%), Dog(83%)
Clonality:
Polyclonal
Specificity:
USP31 Antibody detects endogenous levels of total USP31.
RRID:
AB_2843181
Cite Format: Affinity Biosciences Cat# DF9989, RRID:AB_2843181.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

Deubiquitinating enzyme 31; KIAA1203; Ubiquitin carboxyl terminal hydrolase 31; Ubiquitin carboxyl-terminal hydrolase 31; Ubiquitin specific peptidase 31; Ubiquitin specific processing protease 31; Ubiquitin specific protease 31; Ubiquitin specific proteinase 31; Ubiquitin thioesterase 31; Ubiquitin thiolesterase 31; Ubiquitin-specific-processing protease 31; UBP31_HUMAN; USP 31; USP31;

Immunogens

Immunogen:

A synthesized peptide derived from human USP31, corresponding to a region within N-terminal amino acids.

Uniprot:
Gene(ID):
Expression:
Q70CQ4 UBP31_HUMAN:

Widely expressed.

Sequence:
MSKVTAPGSGPPAAASGKEKRSFSKRLFRSGRAGGGGAGGPGASGPAAPSSPSSPSSARSVGSFMSRVLKTLSTLSHLSSEGAAPDRGGLRSCFPPGPAAAPTPPPCPPPPASPAPPACAAEPVPGVAGLRNHGNTCFMNATLQCLSNTELFAEYLALGQYRAGRPEPSPDPEQPAGRGAQGQGEVTEQLAHLVRALWTLEYTPQHSRDFKTIVSKNALQYRGNSQHDAQEFLLWLLDRVHEDLNHSVKQSGQPPLKPPSETDMMPEGPSFPVCSTFVQELFQAQYRSSLTCPHCQKQSNTFDPFLCISLPIPLPHTRPLYVTVVYQGKCSHCMRIGVAVPLSGTVARLREAVSMETKIPTDQIVLTEMYYDGFHRSFCDTDDLETVHESDCIFAFETPEIFRPEGILSQRGIHLNNNLNHLKFGLDYHRLSSPTQTAAKQGKMDSPTSRAGSDKIVLLVCNRACTGQQGKRFGLPFVLHLEKTIAWDLLQKEILEKMKYFLRPTVCIQVCPFSLRVVSVVGITYLLPQEEQPLCHPIVERALKSCGPGGTAHVKLVVEWDKETRDFLFVNTEDEYIPDAESVRLQRERHHQPQTCTLSQCFQLYTKEERLAPDDAWRCPHCKQLQQGSITLSLWTLPDVLIIHLKRFRQEGDRRMKLQNMVKFPLTGLDMTPHVVKRSQSSWSLPSHWSPWRRPYGLGRDPEDYIYDLYAVCNHHGTMQGGHYTAYCKNSVDGLWYCFDDSDVQQLSEDEVCTQTAYILFYQRRTAIPSWSANSSVAGSTSSSLCEHWVSRLPGSKPASVTSAASSRRTSLASLSESVEMTGERSEDDGGFSTRPFVRSVQRQSLSSRSSVTSPLAVNENCMRPSWSLSAKLQMRSNSPSRFSGDSPIHSSASTLEKIGEAADDKVSISCFGSLRNLSSSYQEPSDSHSRREHKAVGRAPLAVMEGVFKDESDTRRLNSSVVDTQSKHSAQGDRLPPLSGPFDNNNQIAYVDQSDSVDSSPVKEVKAPSHPGSLAKKPESTTKRSPSSKGTSEPEKSLRKGRPALASQESSLSSTSPSSPLPVKVSLKPSRSRSKADSSSRGSGRHSSPAPAQPKKESSPKSQDSVSSPSPQKQKSASALTYTASSTSAKKASGPATRSPFPPGKSRTSDHSLSREGSRQSLGSDRASATSTSKPNSPRVSQARAGEGRGAGKHVRSSSMASLRSPSTSIKSGLKRDSKSEDKGLSFFKSALRQKETRRSTDLGKTALLSKKAGGSSVKSVCKNTGDDEAERGHQPPASQQPNANTTGKEQLVTKDPASAKHSLLSARKSKSSQLDSGVPSSPGGRQSAEKSSKKLSSSMQTSARPSQKPQ

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
92
Horse
92
Bovine
92
Sheep
92
Dog
83
Chicken
70
Xenopus
0
Zebrafish
0
Rabbit
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

Research Backgrounds

Function:

May recognize and hydrolyze the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins (By similarity).

Tissue Specificity:

Widely expressed.

Family&Domains:

Belongs to the peptidase C19 family.

References

1). CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages. Cardiovascular research, 2024 (PubMed: 39028686) [IF=10.2]

Application: WB    Species: Mouse    Sample:

Figure 5CircARCN1 affects the interaction between HuR and USP31 mRNA, and down-regulates USP31. (A) Venn diagram analysis of all mRNAs negatively correlated with circARCN1 in our RNA-Seq data (n = 9, data in Figure 1A and B), HuR target mRNAs identified by THP-1 FLASH-Seq, HuR target mRNAs in the ENCORI database (ClusterNum > 100), and HuR consensus target genes from a previous study.36 USP31 was identified to interact with HuR and was negatively correlated with circARCN1 in RNA-Seq data. (B) Correlation analysis of circARCN1 with USP31 (RNA-Seq data in Figure 1A and B, n = 9). (C) Correlation analysis of circARCN1 with USP31 in PBMC samples (n = 45), by RT-qPCR. (D) RT-qPCR analysis of USP31 mRNA levels after circARCN1 knockdown or overexpression in THP-1 macrophages. The results demonstrated that circARCN1 could regulate USP31 mRNA levels. (E) Western blot analysis of USP31 protein levels after circARCN1 knockdown or overexpression in THP-1 macrophages. The results demonstrated that circARCN1 could regulate USP31 protein levels. (F) FLASH-Seq, using the anti-HuR antibody, performed in THP-1 macrophages, with circARCN1 overexpression or knockdown, identified two BSs (BS1 and BS2) of HuR in the 3′UTR of USP31 mRNA. (G) Diagram showing USP31 3′UTR lacking BS1 (△1), BS2 (△2), or both BSs (△1–3). RNA pull-down assays were performed in THP-1 lysate, followed by western blot analysis, comparing the binding capacity with HuR among these mutants. (H) RIP experiment was conducted in THP-1, using anti-HuR antibody, followed by RT-qPCR analysis, showing the interaction between HuR and USP31 mRNA. (I) RIP assays comparing USP31 mRNA-binding capacity among HuR deletion mutants (HuR△1, HuR△2, and HuR△3). (J) RIP assays using anti-HuR antibody were conducted in THP-1, with circARCN1 knockdown or overexpression. CircARCN1 knockdown enhanced the interaction between HuR and USP31 mRNA, while circARCN1 overexpression weakened their interaction. (K and L) RNA stability assay. RNA synthesis was blocked with 5 μg/mL actinomycin D for indicated hours in THP-1. HuR knockdown in THP-1 resulted in decreased USP31 mRNA stability (K). CircARCN1 knockdown increased USP31 mRNA stability, while HuR silencing could abolish this effect (L). (M and N) Western blot analysis was conducted to examine the impact of USP31 silencing on the effects of circARCN1 knockdown in THP-1 macrophages (M). Protein levels were quantified in three independent experiments, as depicted in the bar-diagrams (N). The results demonstrated that USP31 silencing counteracted the effects of circARCN1 knockdown on NF-κB quiescence and downregulation of TNF-α, MMP9, and ICAM1. All data are presented as mean ± S.E.M. ns indicated no significance, *P < 0.05, **P < 0.01 (Pearson’s correlation test for B and C; two-tailed Student’s t-test for D–E, H, J, and N).

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.